Pagine elettroniche ; Caso Contributivo
Una mielite di origine incerta
A myelitis of uncertain origin
Giulia Barbato, Giorgia Monti, Laura Leoni, Maddalena Marchesi, Elena Pavlidis, Gaetano Cantalupo, Francesco Pisani, Nicola Carano
Dipartimento Materno Infantile, Unitŕ Clinica Pediatrica, Azienda Ospedaliero-Universitaria di Parma
Giugno 2011 - pagg. 397 -398
Abstract
Transverse myelitis is a neurologic syndrome caused by acute or subacute inflammation of the spinal cord. Since its incidence is about 0.5/100,000 children/year, transverse mielitis is included in the group of rare diseases. The pathogenesis of the disease includes an abnormal activation of the immune system of the spinal cord, which leads to axonal demyelination. Transverse mielitis occurs expecially after infections or vaccines; it is often due to autoimmune diseases; rarely, it is a paraneoplastic syndrome. When a direct cause cannot be found, it is called idiopathic. The clinic includes limb and leg weakness, sensory disturbance, bowel and bladder dysfunction, back and radicular pain. The prognosis is extremely variable: about one third of the patients recovers without consequences, one third has some disability left, one third gets an important rate of disability without recovery. We report a case of a 13-year-old girl affected by transverse myelitis who rapidly developed leg paresthesia and weakness, difficulty in deambulation, sensor and sphincter deficits. Since all the tests made during the hospitalization to find a possible cause were negative, no pathogenetic association could be done.
Parole chiave
Suggerite dall'AI
Classificazione MeSH
Bibliografia
1.Slade BA, Leidel L, Vellozzi C, et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA 2009;302:750-7.
2.Bhat A, Naguwa S, Cheema G, et al. The epidemiology of transverse myelitis. Autoimmunity Reviews 2010;9:A395-9.
3.Zandman-Goddard G, Levy L, Weiss P, et al. Transverse myelitis associated with chronic hepatitis C. Clin Exp Rheumatol 2003;21:111-3.
4.LaRovere KL, Raju GP, Gorman MP. Postvaricella acute transverse myelitis in a previously vaccinated child. Pediatr Neurol 2008;38:370-2.
5.Weng WC, Peng SB, Chou YT, et al. Mycoplasma pneumoniae-associated transverse myelitis and rhabdomyolysis. Pediatr Neurol 2009; 40:128-30.
6.Veena K, Suvasini S, Jitendra S, et al. Childhood acute transverse myelitis: clinical profile, outcome, and association with antiganglioside antibodies. J Child Neurol 2009;24:466-71.
7.Nobre V, Silva LC, Ribas JC, et al. Schistosomal myeloradiculopathy due to Schistosoma mansoni: report on 23 cases. Mem Inst Oswaldo Cruz 2001;96 (Suppl):137-41.
8.Agmon-Levin N, Kivity S, Szyper-Kravitz M, et al. Transverse myelitis and vaccines: a multi-analysis. Lupus 2009;18:1198-204.
9.Klein N, Ray P, Carpenter D, et al. Rates of autoimmune disease in Kaiser Permanent for use in vaccine adverse event studies. Vaccine 2010;1062-8.
10.Harisdangkul V, Doorenbos D, Subramony SH. Lupus transverse myelopathy: better outcome with early recognition and aggressive high-dose intravenous corticosteroid pulse treatment. J Neurol 1995;242:326-31.
11.Kovacs B, Lafferty TI, Brent LH, et al. Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 2000;59:120-4.
12.Birnbaum J, Petri M, Thompson R, et al. Distinct subtypes of myelitis in systemic lupus erythematosus. Arthritis Rheum 2009;60:3378-87.
13.Rogers SJ, Williams CS, Roman GC. Myelopathy in Sjogren’s syndrome: role of nonsteroidal immunosuppressants. Drugs 2004;64:123-32.
14.Bhinder S, Harbour K, Majithia V. Transverse myelitis, a rare neurological manifestation of mixed connective tissue disease - a case report and a review of literature. Clin Rheumatol 2007;26:445-7.
15.Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002;59:499-505.
16.Román GC. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2003;60:730-1.
17.Tristano AG. Autoimmune disease associated with transverse myelitis. Review. Invest Clin 2009;50:251-70.
18.Defresne P, Meyer L, Tardieu M, et al. Efficacy of high dose steroid therapy in children with severe acute transverse myelitis. J Neurol Neurosurg Psychiatry 2001;71:272-4.
19.Debette S, de Seze J, Pruvo JP, et al. Long-term outcome of acute and subacute myelopathies. J Neurol 2009;256:980-8.
20.Cree BA, Wingerchuk DM. Acute transverse myelitis: is the “idiopathic form” vanishing? Neurology 2005;65:1857-8.
Corrispondenza: giuliabarbato@libero.it